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Objectives. To investigate self-reported health-related quality of life (HrQoL) in children and adolescents with chronic medical
conditions compared with siblings/peers. Methods. Group 1 (6 treatment centers) consisted of 74 children/adolescents aged 8–
16 years with hereditary bleeding disorders (HBD), 12 siblings, and 34 peers. Group 2 (one treatment center) consisted of 70
children/adolescents with stroke/transient ischemic attack, 14 siblings, and 72 peers. HrQoLwas assessed with the “revised KINDer
Lebensqualita¨tsfragebogen” (KINDL-R) questionnaire. Multivariate analyses within groups were done by one-way ANOVA and
post hoc pairwise single comparisons by Student’s 𝑡-tests. Adjusted pairwise comparisons were done by hierarchical linear
regressions with individuals nested within treatment centers (group 1) and by linear regressions (group 2), respectively. Results.
No differences were found in multivariate analyses of self-reported HrQoL in group 1, while in group 2 differences occurred in
overall wellbeing and all subdimensions. These differences were due to differences between patients and peers. After adjusting for
age, gender, number of siblings, and treatment center these differences persisted regarding self-worth (𝑝 = .0040) and friend-related
wellbeing (𝑝 < .001).Conclusions. In children withHBD,HrQoLwas comparable to siblings and peers. In children with stroke/TIA
HrQoL was comparable to siblings while peers, independently of relevant confounder, showed better self-worth and friend-related
wellbeing.
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1. Introduction
Hereditary bleeding disorders (HBD) encompass a hetero-
geneous group of diseases with the most frequent clinical
entities being vonWillebrand disease (vWD) and hemophilia
A (HA). Their incidence is overall low but the individ-
ual burden of disease remains high despite encouraging
advances in secondary prevention including prophylactic
factor replacement and enhanced treatment options such as
optimized joint disease prevention and improved inhibitor
management [1–4]. When patients with HA receive optimal
medical care and when they are not affected by blood-
borne viruses (such as HIV or HCV) they may face a life
expectancy similar to that of the general population [5,
6]. It remains unclear whether quantitative gains in terms
of life expectancy are accompanied by qualitative gains in
self-reported health-related quality of life (HrQoL) whether
these gains are apparent already in young persons with HA.
Recent studies found in children and adolescents with HA
and other HBD HrQoL comparable to or even better than
population norms. Poon et al. [7] found in their study in
Californian children with HA (mean age 9.7 years) HrQoL
(assessed with the generic PedsQL) similar to or better
than population norms. Likewise Bullinger et al. [8] found
generic HrQoL in more than 300 children with hemophilia
in 6 European countries higher compared to children with
other chronic medical conditions. Gringeri et al. [9] assessed
HrQoL in 20 treatment centers in 6 European countries
using the hemophilia-specific Haemo-QoL. The 4–16-year-
old patients with hemophilia A and hemophilia B showed
solely impairments in family-related wellbeing in 4–7-year-
old patients, whereas 8–16-year-old patients showed impair-
ments in friend-related wellbeing compared to younger
patients [9].The total score of the Haemo-QoL questionnaire
showed no overall differences between age groups but dif-
ferences between treatment groups (on-demand treatment
versus prophylactic treatment). Alpkilic¸ Baskirt et al. [10]
compared a group of 71 patients with HA, 14–34-year-old,
matched for age and gender to healthy controls and found
in five out of eight domains of the SF-36 significantly higher
scores in healthy controls compared to the patient group.
A similar approach was chosen by Salem and Eshghi [11]
from Tehran who investigated 46 patients with HBD aged 2–
15 years. These patients were likewise compared to age and
gender matched controls. Here the authors found no differ-
ences between patients and controls regarding oral HrQoL
(using the Child Perception Questionnaire, CPQ, items 1–
9) as well as regarding functional limitations, emotional and
social wellbeing (CPQ, items 10–24).
However, findings were compared between subgroups
of patients or between hemophilic patients and patients
with other chronic medical conditions or with population
norm data. Similarly a recent narrative review of studies
evaluating self-reported quality of life in children with var-
ious medical conditions found most investigators comparing
patients’ self-reports with general population or age-matched
control/reference children [13].
To the best of our knowledge few studies have investigated
HrQoL in children with HBD in comparison with their
siblings or with healthy individuals deriving from their social
environment. Therefore aim of the current investigation was
to compare self-reported measures of HrQoL in a group of
children and adolescents with a chronic medical condition
but no expected functional restrictions,HBD, to their siblings
and peers. Data from an own investigation in children
with stroke/transient ischemic attack (TIA) allowed repeating
these comparisons between patients, siblings, and peers in a
disease group with neonatal or childhood stroke at a median
age of 6.3 years [14]. The majority of these children exhibited
at least one moderate neurological deficit with functional
restrictions [14].
2. Material and Methods
2.1. Inclusion Criteria. Inclusion criteria were as follows:
pediatric patients with HBD, aged 8 to 16 years, admitted
to 6 specialized treatment centers in Germany. Patients were
recruited during their routine outpatient’s visits in clinics
in major cities in Germany (2 centers in Berlin [𝑛 = 36],
Duisburg [𝑛 = 10], Leipzig [𝑛 = 3], Mu¨nster [𝑛 = 15], and
Munich [𝑛 = 11]).
2.2. Exclusion Criteria. Exclusion criteria were as follows:
patients aged less than 8 years at the time of completion of
the questionnaire, non-German speaking families, children
whowere unable to understand and answer the questions due
to severe disabilities, and families without written informed
consent.
2.3. Study Population. Study participants were enrolled
between August 2008 and August 2011 (patients with HBD)
and in January 2010 (patients with TIA/stroke). Out of 354
initial study participants 37 were older than 17 years (10.5%).
Of the remaining 299 study participants, 23 did not fill out
the “revised KINDer Lebensqualita¨tsfragebogen” (KINDL-
R, [15]). Thus the final dataset consists of 144 patients. Of
these 74 were patients withHBD (51.4%) and 70 were patients
with stroke or TIA (48.6%). The 74 patients with HBD were
patients with hemophilia A and hemophilia B (𝑛 = 36),
patients with von Willebrand disease type 2 and type 3 (𝑛 =
22), patients with hereditary fibrinogen deficiency (𝑛 = 5),
and patients with factor V, VII, and XI deficiency (𝑛 =
9). Of these, 12 healthy siblings were willing to participate
in this cross-sectional investigation. Additionally, data were
collected from 34 healthy unrelated peers recruited from the
same catchment areas as the patients [kindergarten/school
mates and friends]. Data from patients with stroke or TIA,
their siblings (𝑛 = 14), and peers (𝑛 = 72) were derived from
a previous investigation at the University of Mu¨nster [14].
Patients completed the questionnaires during a routine
ambulatory follow-up visit (i) by themselves or (ii) if unable
to read and write with the help of a study nurse but not with
the help of their parents or other accompanying persons.
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Table 1: Basic sociodemographic characteristics of all study participants with complete KINDL-R questionnaires, 𝑛 = 276.
Variable Patients Healthy controls
Patients with HBD (𝑛 = 74) Stroke or TIA (𝑛 = 70) Siblings (𝑛 = 26) Peers (𝑛 = 106)
Female gender, 𝑛 (%) 11 (14.9%) 44 (62.9%) 17 (65.4%) 37 (34.9%)
Age in years, mean ± SD 11.5 ± 2.3 11.6 ± 2.5 12.3 ± 2.5 10.5 ± 2.4
Number of siblings
0 20 (27.0%) 6 (8.6%) 0 (0%) 10 (9.4%)
1 30 (40.5%) 34 (48.6%) 18 (69.2%) 45 (42.5%)
2 17 (23.0%) 24 (34.3%) 5 (19.2%) 40 (37.7%)
3 or more 7 (9.5%) 4 (5.7%) 3 (11.5%) 7 (6.6%)
Missing data 0 (0%) 2 (2.9%)# 0 (0%)# 4 (3.8%)
Education
Primary school 31 (41.9%) 25 (35.7%) 9 (34.6%) 61 (57.5%)
Secondary modern school 18 (24.3%) 19 (27.1%) 9 (34.6%) 19 (17.9%)
Secondary school 22 (29.7%) 12 (17.1%) 7 (26.9%) 23 (21.7%)
Special school 3 (4.1%) 10 (14.3%) 0 (0%) 1 (0.9%)
Missing data 0 (0%) 4 (5.7%)# 1 (3.8%)# 2 (1.9%)#
KINDL-R: revised KINDer Lebensqualita¨tsfragebogen; HBD: hereditary bleeding disorders (36 patients with hemophilia A and hemophilia B, 22 patients with
vonWillebrand disease type 2 and type 3, 5 patients with hereditary fibrinogen deficiency, and 9 patients with factor V, VII, and XI deficiency); TIA: transient
ischemic attack; # does not sum up to 100% due to rounding errors.
2.4. HrQoL Outcome. The “revised KINDer Lebensquali-
ta¨tsfragebogen” (KINDL-R) questionnaire [15] is a generic
instrument to assess HrQoL and was originally developed
in German language (http://www.kindl.org/). This 24-item
self-administered or proxy-report questionnaire generates
a total score (overall wellbeing) as well as scores for 6
subscales (physical wellbeing, psychological wellbeing, self-
worth, family-related wellbeing, friend-related wellbeing,
and school-related wellbeing). Scores range from 0 to 100,
with higher values indicating better Hr-QoL. The KINDL-
R instrument is validated for use in healthy children and
pediatric patients aged 4 to 16 years, in 3 age groups (4 to
7 years/8 to 12 years/13 to 16 years). Out of 17,000 children
and adolescents participating in a representative population
sample, the German Health Survey for Children and Adoles-
cents (Studie zur Gesundheit von Kindern und Jugendlichen
in Deutschland, KIGGS), more than 6,800 completed the
KINDL-R questionnaire [12]. The psychometric properties
for children ≥ 11 years were published in 2009 [12]. Data on
the number of siblings and the current educational status
were additionally collected.
2.5. Statistics. Metric variables are presented as mean ±
standard deviation. Multivariate comparisons of HrQoL
between patients, siblings, and peers were calculated using
one-way ANOVA. In case of differences between groups
pairwise single comparison was done by Student’s 𝑡-test
for independent subgroups. To account for multiple testing
(overall 3 tests) the 𝑝 value for this test procedure was
Bonferroni-corrected to 𝑝 < .0167. Adjusted pairwise com-
parisons were by hierarchical linear models with random
intercepts for treatment center (Proc mixed in SAS, using the
default residual maximal likelihood estimation method for
the covariance parameters and a random intercept assuming
an unstructured covariance matrix). Models were adjusted
for age, gender, number of siblings, and school education.
To account for multiple testing (overall 7 comparisons in
KINDL-R total score and 6 subdimensions) the 𝑝 value for
these analyses was Bonferroni-corrected to 𝑝 < .0071.
Otherwise a 𝑝 value < .05 was considered statistically sig-
nificant. Internal consistency of the KINDL-R questionnaire
was examined by Cronbach’s alpha [𝛼]; Cronbach’s 𝛼 values
above .70 were considered acceptable. All statistical analyses
were performed using SPSS software (version 23.0, SPSS Inc.,
Chicago, Illinois, US) and SAS 9.2 (Cary, North Carolina,
US), respectively.
3. Results
In patients with HBD more than 40% (22 of 52 complete
datasets) were in need of prophylactic substitution and
additionally 16/52 (30.89%) were in need of both prophylactic
and on-demand factor substitution. Mean age of the study
participants with HBD was 11.5 years while the mean age of
study participants with stroke/TIAwas 11.6 years (see Table 1).
The majority of patients had one sibling, while 20 (27%)
patients with HBD and 6 (8.6%) patients with stroke/TIA
had no siblings. Less than 5% of children with HBD attended
other than mainstream schools (e.g., schools for physically
handicapped children). The majority of children attended
secondary schools.
Multivariate analyses within patients, siblings, and peers
revealed no differences in self-reported overall wellbeing and
all KINDL-R subdimensions in group 1 (see Figure 1; all 𝑝 >
.05). In group 2, differences occurred in multivariate analyses
in self-reported overall wellbeing and all subdimensions
(overall wellbeing 𝑝 < .001, physical wellbeing 𝑝 = .016,
emotional wellbeing 𝑝 = .007, self-worth 𝑝 = .046, family-
related wellbeing 𝑝 = .010, friend-related wellbeing 𝑝 < .001,
and school-related wellbeing 𝑝 = .003). When testing for
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Figure 1: Self-reported quality of life in patients with hereditary bleeding disorders and their siblings and peers. KINDL-R: revised KINDer
Lebensqualita¨tsfragebogen; black circles represent outliers greater than 1.5 times the interquartilrange (IQR).
pairwise differences in group 2 (see Figure 2), no differences
were seen between patients and their siblings while signif-
icant differences were apparent between patient and peers
in overall wellbeing and all subdimensions (all 𝑝 < .016)
and between siblings and peers regarding family-related and
school-related wellbeing, respectively (both 𝑝 < .016). In
adjustedmultivariate analyses, group 1 showed no differences
in self-reported HrQoL between patients and siblings and
between patients and peers, respectively (Table 2), while
differences were apparent in group 2 between patients with
stroke/TIA and their healthy peers regarding self-worth and
friend-related wellbeing (Table 3).
The psychometric characteristics of the KINDL-R ques-
tionnaires, that is, the internal consistencies of self-reported
KINDL-R questionnaires, are displayed in Table 4. Taking a
cut-off of 𝛼 = 0.7, overall wellbeing in both patients and
healthy controls met the definition of acceptable internal
consistency, as did the internal consistency in the repre-
sentative German population sample, the KIGGS-study (last
column in Table 4). Internal consistency of the subdimension
was somewhat lower but followed pattern comparable to the
population norms deriving from the KIGGS-study. Only one
subdimension, friend-related wellbeing in healthy controls,
showed poor results (Cronbach’s 𝛼 below 0.5). However,
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Figure 2: Self-reported quality of life in patients with stroke/transient ischemic attack (TIA) and their siblings and peers. KINDL-R: revised
KINDer Lebensqualita¨tsfragebogen; ∗𝑝 < .0167 (Bonferroni correction); ∗∗𝑝 < .001 (results of post hoc pairwise single comparisons); black
circles represent outliers greater than 1.5 times the interquartilrange (IQR).
several other subdimensions (emotional wellbeing and
school-related wellbeing) showed a reliability just above the
lower threshold of a modest reliability (Cronbach’s 𝛼 between
0.5 and < 0.7). Comparison is limited by the fact that norm
data were solely available for the age group of 11 years and
older.
4. Discussion
Themost relevant finding in this investigation was the overall
good health-related quality of life (HrQoL)—as measured
with a generic instrument, the KINDL-R questionnaire—in
children with hereditary bleeding disorders. No differences
in HrQoL occurred compared with their siblings. In children
with stroke/TIA, differences in self-reported HrQoL were
apparent in univariate analyses and related to differences
between patients and their peers. These differences in self-
reported HrQoL remained in multivariate models for self-
worth and friend-related wellbeing. Internal consistency of
the KINDL-questionnaires was good for overall wellbeing for
all study groups and followed pattern of population based
findings for the KINDL-R subscales.
When considering the adjusted differences between
patients and siblings and patients and peers, respectively, in
this investigation, observed differences in overall wellbeing
were small (less than one point) indicating comparable
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Table 2: Differences in self-reported quality of life between patients with hereditary bleeding disorders and their siblings and peers,
respectively, measured with the KINDL-questionnaire (overall wellbeing and all subscales); results of hierarchical linear regression models
with random intercepts for treatment center.
KINDL-R scores Patients compared with healthy siblings Patients compared with healthy peers
𝛽
𝑥
95%-CI 𝑝 𝛽
𝑥
95%-CI 𝑝
Overall wellbeing −0.3 (−7.3 to 6.6) .92 −0.5 (−4.5 to 3.5) .81
Physical wellbeing −0.1 (−11.9 to 11.8) .99 3.3 (−3.8 to 10.4) .36
Emotional wellbeing 0.9 (−7.3 to 9.0) .21 0.5 (−4.6 to 5.6) .84
Self-worth −2.4 (−16.4 to 11.6) .74 −6.6 (−14.4 to 1.1) .09
Family-related wellbeing 0.7 (−9.0 to 10.4) .88 1.7 (−3.9 to 7.3) .54
Friend-related wellbeing 0.4 (−11.4 to 12.2) .38 0.3 (−6.8 to 7.4) .93
School-related wellbeing −1.5 (−13.4 to 10.4) .80 0.2 (−6.7 to 7.1) .95
KINDL-R: revised KINDer Lebensqualita¨tsfragebogen; models adjusted for age, gender, number of siblings, and school education.
Table 3: Differences in self-reported quality of life between patients with stroke or transient ischemic attack (TIA) and their siblings and
peers, respectively, measured with the KINDL-questionnaire (overall wellbeing and all subscales); results of linear regression models.
KINDL-R scores Patients compared with healthy siblings Patients compared with healthy peers
𝛽
𝑥
95%-CI 𝑝 𝛽
𝑥
95%-CI 𝑝
Overall wellbeing −0.8 (−6.6 to 5.1) .80 −0.5 (−4.5 to 3.5) .81
Physical wellbeing 0.8 (−11.0 to 12.6) .90 −5.1 (−11.7 to 1.5) .13
Emotional wellbeing −2.8 (−13.2 to 7.6) .59 −6.7 (−12.2 to −1.1) .0185
Self-worth −1.7 (−3.9 to 0.5) .13 −8.2 (−13.8 to −2.7) .0040
Family-related wellbeing −5.7 (−14.4 to 2.9) .19 −4.4 (−9.6 to 0.7) .09
Friend-related wellbeing −5.6 (−17.1 to 5.9) .33 −13.6 (−19.8 to −7.3) <.001
School-related wellbeing −0.9 (−11.7 to 9.8) .86 −7.0 (−13.4 to −0.6) .0315
KINDL-R: revised KINDer Lebensqualita¨tsfragebogen; models adjusted for patient group (patients with hereditary bleeding disorders versus patients with
stroke/TIA), age, gender, number of siblings, and school education; significant results are shown in bold (𝑝 < .0071, Bonferroni correction).
Table 4: Internal consistency (Cronbach’s alpha) of the self-reported KINDL-R questionnaire (overall wellbeing and all subscales) in all
patients (HBD and stroke/TIA), their healthy controls, and normative data of 11–17-year-old study participants deriving from the German
National Health Interview and Examination Survey for Children and Adolescents, KIGGS.
KINDL-R scores Patients# (𝑛 = 144) Healthy controls# (𝑛 = 106)
11–17-year-old population based
children from the KIGGS-study$
(𝑛 = 7,649)
Overall wellbeing 0.79 0.83 0.82
Physical wellbeing 0.63 0.71 0.59
Emotional wellbeing 0.53 0.51 0.59
Self-esteem 0.63 0.66 0.68
Family-related wellbeing 0.65 0.63 0.72
Friend-related wellbeing 0.60 0.46 0.53
School-related wellbeing 0.51 0.69 0.53
KINDL-R: revised KINDer Lebensqualita¨tsfragebogen; HBD: hereditary bleeding disorders; TIA: transient ischemic attack. #The number of persons included
in the analyses varies slightly between subdimensions, depending on the completeness of the KINDL-R questionnaire; KIGGS: German National Health
Interview and Examination Survey for Children and Adolescents. $Data taken from Erhart et al. [12].
HrQoL between groups. However, when looking for differ-
ences in HrQoL subdimensions, it appeared that differences
between patients and siblings as well as between patients
and peers in group 1 (hereditary bleeding disorders) were
altogether less pronounced than in group 2 (stroke, TIA).
Furthermore, in this group absolute differences were more
pronounced in the comparison of patients and peers than in
the comparison of patients and their siblings. Across all four
comparisons (seeTables 2 and 3) absolute differences between
groups were largest in self-worth. Choosing an arbitrary
cut-off of 5 points for a clinical significant and meaningful
difference between two groups, patients with stroke/TIA
showed in five out of six KINDL-R domains lower HrQoL
than their peers (of these two showing statistical significance
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either, even when applying strict constraints due to multi-
ple testing) while there were solely two domains clinically
relevant affected between patients with stroke/TIA and their
siblings and only one in group 1.Thus intense medical care of
patients with HBD (38 out of 52 HBD patients were in need
for prophylactic and/or on-demand factor substitution) may
enable young patients a quality of life similar to their sisters,
brothers, and friends. The probable clinical (although in this
investigation not statistical) significant impairment in self-
worth in patientswithHBDcompared to their healthy friends
may nevertheless indicate a need for psychological support
and for improvement of self-esteem.
In other chronic medical conditions with no necessarily
functional restrictions in daily life comparable findings were
reported: no differences between HrQoL in juvenile patients
with sickle cell disease and their siblings were found, but sib-
lings scored in three out of 10 domains of theKIDSCREEN-52
questionnaire worse than Dutch population norms [16].
In children with stroke/TIA with ongoing neurological
deficits in >90% [14] clinical relevant impairments were
more apparent. This concerned—apart from self-worth—
additional social dimensions, both in comparison to siblings
and, even more pronounced, in comparison to peers. When
looking at absolute values, differences weremore pronounced
in psychological and social domains than in physical wellbe-
ing.
Our findings in patients with stroke/TIA reflected earlier
findings from other groups of children and adolescents with
chronicmedical conditions leading to functional restrictions:
in patients with cardiac disorders, Manlhiot et al. [17] found
in 10–20-year-old patients after Fontan procedure compared
with their healthy siblings impaired HrQoL in all domains
of the generic Peds-QoL questionnaire. Adult survivors of
Tetralogy of Fallot (224 survivors out of 1,693 repairs over a
period of 44 years) showed likewise impaired general health
and physical functioning (as assessed with the generic SF-
36 questionnaire) compared with their siblings, especially
in those with surgery at older age [18]. Likewise in patients
with neurologic conditions, Mowry et al. [19] found worse
HrQoL in childrenwithmultiple sclerosis (mean age 14 years)
in comparison with their siblings; HrQoL was evaluated
with the Pediatric Quality of Life Inventory and impair-
ment in HrQoL was associated with neurologic deficits.
Likewise impaired HrQoL in juvenile patients with other
severe chronic medical conditions in comparison with their
healthy siblings was found in children with cystic fibrosis
[20], in children with acute lymphoblastic leukemia [21], in
children with transfusion-dependent thalassemia, except for
the social-relationship domain of the WHOQOL-Bref [22],
and in children with hereditary retinal disorders [23].
Additional Points
These findings are based on small sample sizes in a cross-
sectional study design, all analyses were exploratory, and
results should therefore be interpreted with caution. There
were no data on nonresponder; thus the representativeness
regarding the source population remains unclear. The inter-
correlation among test itemsmeasuredwithCronbach’s𝛼was
good: in all study subgroups overall wellbeing scores showed
an acceptable internal consistency (𝛼 > 0.7). In subdimen-
sions of theKINDL-R score however some subgroups showed
poorer results but in the representative KIGGS population
sample (only children ≥ 11 years) some subdimensions were
also below acceptable internal consistency [12]. The poor
internal consistency in healthy controls in one subdimension
and the modest reliability in all but one subdimension in
both patients and healthy controls may reflect limitations of
the questionnaire per se as well as specific limitations of the
small sample size in this investigation. When combining all
study subgroups Cronbach’s 𝛼 was 0.82 and subscales ranged
between 0.52 and 0.67 (data not shown). Thus, the use of
the generic KINDL-R questionnaire seems applicable in this
specific setting. Self-reported measures of health status are
regarded as the primary method for assessing HrQoL in
children and adolescents once they have reached a certain age
and level of cognitive development [24, 25]. Longitudinal data
were necessary to elucidate whether adolescents or adults
with HBD who showed as children a HrQoL comparable to
population norms exhibit over time, relative to the population
level, a deterioration of their self-reportedHr-QoL, especially
regarding physical wellbeing.
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